Measuring Toxicity in Phase I Clinical Trials--Letter

Clin Cancer Res. 2016 Apr 1;22(7):1828. doi: 10.1158/1078-0432.CCR-15-3043.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use
  • Clinical Trials, Phase I as Topic
  • Clinical Trials, Phase II as Topic
  • Humans
  • Maximum Tolerated Dose*
  • Neoplasms / drug therapy*

Substances

  • Antineoplastic Agents